麻豆社

Ed Butler investigates the mounting problem of antimicrobial resistance, and what can be done to prevent a crisis in treatments. He speaks to Dr Marc Sprenger, director of the World Health Organisation Secretariat for antimicrobial resistance and Lord Jim O'Neill, the former Goldman Sachs chief economist who was hired by the UK government to lead a comprehensive study into the problem. Are pharmaceutical companies doing enough? We hear from Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations.

(Photo: Stock image of pharmaceuticals, Credit: Getty Images)